email   Email Us: info@lupinepublishers.com phone   Call Us: +1 (914) 407-6109   57 West 57th Street, 3rd floor, New York - NY 10019, USA

Lupine Publishers Group

Lupine Publishers

  Submit Manuscript

ISSN: 2690-5787

LOJ Immunology  & Infectious Disease

Opinion Open Access

A New Multidisciplinary Strategy for Using Novel Tunable Immune Response (TIR) Biomaterial Platform Technology as the New Alternative for Treating Immuno-based Diseases

Volume 1 - Issue 2

CC Chu*

  • Author Information Open or Close
    • Rebecca Q. Morgan ‘60 Endowed Chair Professor, College of Human Ecology, Cornell University Ithaca, USA

    *Corresponding author: CC Chu, Endowed Chair Professor, College of Human Ecology, Cornell University Ithaca, NY, USA

Received: August 15, 2019;   Published: August 28, 2019

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Innovation in technology is the key element to modernize medical treatment and will have a significant impact on all phrases of our lives, particularly the healthcare upon aging population. Many diseases have the common root on immunology, particularly inflammation, and the current advanced immunotherapy has all based on the biological approach like cytokines to alter the immune response for achieving better therapeutic outcomes. At here, I would like to propose a new multidisciplinary strategy as a new alternative for treating immuno-based diseases via the use of a novel family of tunable immune response (TIR) biomaterial platform technology.

Opinion|

https://www.high-endrolex.com/21